CORZZ
Core Scientific, Inc./tx Russell 3000
$12.47Close
$3.9BMarket cap
$12.47 – $17.5952-week range
Highlights
Cautions
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
29%
1wk
down 5.2%
price change
1mo
—
price change
12-month return
down 19%
total, dividends included
F-score
4 / 9
Weak
Altman Z″
-6.45
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
down 5.3%
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
down 38%
year on year
EPS growth
—
latest quarter
Sales growth
up 109%
latest quarter · +64 pts
ROE
—
return on equity
Free cash margin
down 141%
-$450.8M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- short-term liquidity weakened
- issued more shares
- gross margin narrowed
- assets working less efficiently
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
Trade setup
ATR%
—
RS
—
vs the universe
Trend
—
trend template
Relative volume
—
vs 50-day average
Up/down volume
—
50 sessions
Implied move
—
no scheduled report
Screen verdict
Did not qualify for any screen.
Warning signs
- Accounts declared unreliable The company told the SEC that previously issued financial statements should no longer be relied upon. Every figure on this page that predates that filing is drawn from statements the company itself has withdrawn.
- Liabilities exceed assets Shareholders' equity is negative at -$962.7M as of Dec 31, 2025. What is left for shareholders after creditors is, on the balance sheet, less than nothing.
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Shareholders diluted The share count rose 7.4% over the year, from 293m to 314m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
- Gross margin narrowing Gross margin fell from 23.7% to 11.9%. The company is keeping less of each dollar of sales than it did a year ago.
- Revenue shrinking Revenue fell 37.5% over the year, from $510.7M to $319.0M.
Last reported
Jul 28, 2026
Financials
- Gross 12%
- Net -90%
- Free cash -141%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $60.3M | $544.5M | $640.3M | $502.4M | $510.7M | $319.0M |
| Gross margin | 16% | 44% | 1% | 25% | 24% | 12% |
| Operating income | -$6.3M | $131.5M | -$2.1B | $9.0M | -$142.1M | -$245.6M |
| Net income | -$12.2M | $47.3M | -$2.1B | -$246.5M | -$1.4B | -$288.6M |
| Net margin | -20% | 9% | -335% | -49% | -282% | -90% |
| Earnings per share | -$0.08 | $0.20 | -$6.30 | -$0.65 | -$5.62 | -$0.91 |
| Free cash flow | -$23.8M | -$56.7M | -$178.8M | $49.0M | -$52.1M | -$450.8M |
| Free cash margin | -39% | -10% | -28% | 10% | -10% | -141% |
| Cash | $8.7M | $117.9M | $15.9M | $50.4M | $836.2M | $311.4M |
| Long-term debt | — | $652.2M | $0 | $684.1M | $1.1B | $1.1B |
| Shareholders' equity | $89.2M | $1.3B | -$409.3M | -$596.9M | -$943.0M | -$962.7M |
| Shares outstanding | — | 271.58m | 375.23m | 386.88m | 292.61m | 314.23m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 28, 2026 | Quarterly ↗ | Jun 30, 2026 | 28d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Mar 2, 2026 | Annual ↗ | Dec 31, 2025 | 61d |
| Oct 24, 2025 | Quarterly ↗ | Sep 30, 2025 | 24d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Aug 7, 2024 | Quarterly ↗ | Jun 30, 2024 | 38d |
| May 9, 2024 | Quarterly ↗ | Mar 31, 2024 | 39d |
| Mar 13, 2024 | Annual ↗ | Dec 31, 2023 | 73d |
| Nov 6, 2023 | Quarterly ↗ | Sep 30, 2023 | 37d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 10, 2026 | Regulation FD ↗ |
| Aug 27, 2026 | Material agreement · New obligation · Regulation FD ↗ |
| Aug 14, 2026 | Regulation FD · Other events ↗ |
| Jul 29, 2026 | Director or officer change · Regulation FD ↗ |
| Jul 28, 2026 | Results · Regulation FD ↗ |
| Jul 28, 2026 | Unregistered share sale · Regulation FD ↗ |
| May 26, 2026 | Director or officer change · Regulation FD ↗ |
| May 15, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Results · Regulation FD ↗ |
| May 6, 2026 | Material agreement · Regulation FD ↗ |
| May 6, 2026 | Material agreement · Agreement ended · New obligation · Other events ↗ |
| May 5, 2026 | Director or officer change ↗ |